4//SEC Filing
Greene Barry E 4
Accession 0001562180-25-003112
CIK 0001597553other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:09 PM ET
Size
8.5 KB
Accession
0001562180-25-003112
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-04-10$6.91/sh−4,862$33,596→ 100,169 total - Award
Common Stock
2025-04-10+19,964→ 105,031 total
Footnotes (1)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 57,040 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 19,964 shares.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001291963
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:09 PM ET
- Size
- 8.5 KB